Kristen R Nichols1, Allison L Petschke1, Emily C Webber2, Chad A Knoderer1. 1. Pharmacy Practice Department, Butler University College of Pharmacy and Health Sciences, Indianapolis, Indiana, United States. 2. Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, United States.
Abstract
BACKGROUND: To maximize resources, the antimicrobial stewardship program at a pediatric tertiary care hospital made pediatric dosing specific guidance within the electronic health record available to all hospitals within the health system. OBJECTIVE: The objective of this study was to compare the appropriateness of antibiotic dosing before and after the implementation of an electronic intravenous (IV) antibiotic order set. METHODS: This was a retrospective cohort study evaluating orders from patients younger than 18 years who received cefepime, piperacillin-tazobactam, tobramycin, or gentamicin at 12 health-system hospitals. Antibiotic dosing regimens and order set use were evaluated in patients who received the specified antibiotics during the 6-month time frame prior to and following electronic order set availability at each hospital. RESULTS: In the before and after implementation periods, 360 and 387 total antibiotic orders were included, respectively. Most orders were gentamicin (55.8% in the before implementation period and 54.5% in the after implementation period) followed by piperacillin-tazobactam (22.5% in the before period and 22.2% in the after period). Overall, 663 orders were classified as appropriate (88.8%). Appropriateness was similar in the before or after implementation periods (87.8 vs. 89.7%, p = 0.415). There was a significant difference in appropriateness if a blank order versus the electronic IV antibiotic order set was used (82.8 vs. 90.5%; p = 0.024). CONCLUSION: No difference in antibiotic appropriateness overall was found in the before and after implementation periods. However, when specifically compared with the appropriateness of dosing when blank order forms were used, dosing was more appropriate when electronic antibiotic order sets were used. Georg Thieme Verlag KG Stuttgart · New York.
BACKGROUND: To maximize resources, the antimicrobial stewardship program at a pediatric tertiary care hospital made pediatric dosing specific guidance within the electronic health record available to all hospitals within the health system. OBJECTIVE: The objective of this study was to compare the appropriateness of antibiotic dosing before and after the implementation of an electronic intravenous (IV) antibiotic order set. METHODS: This was a retrospective cohort study evaluating orders from patients younger than 18 years who received cefepime, piperacillin-tazobactam, tobramycin, or gentamicin at 12 health-system hospitals. Antibiotic dosing regimens and order set use were evaluated in patients who received the specified antibiotics during the 6-month time frame prior to and following electronic order set availability at each hospital. RESULTS: In the before and after implementation periods, 360 and 387 total antibiotic orders were included, respectively. Most orders were gentamicin (55.8% in the before implementation period and 54.5% in the after implementation period) followed by piperacillin-tazobactam (22.5% in the before period and 22.2% in the after period). Overall, 663 orders were classified as appropriate (88.8%). Appropriateness was similar in the before or after implementation periods (87.8 vs. 89.7%, p = 0.415). There was a significant difference in appropriateness if a blank order versus the electronic IV antibiotic order set was used (82.8 vs. 90.5%; p = 0.024). CONCLUSION: No difference in antibiotic appropriateness overall was found in the before and after implementation periods. However, when specifically compared with the appropriateness of dosing when blank order forms were used, dosing was more appropriate when electronic antibiotic order sets were used. Georg Thieme Verlag KG Stuttgart · New York.
Authors: Elizabeth B Fortescue; Rainu Kaushal; Christopher P Landrigan; Kathryn J McKenna; Margaret D Clapp; Frank Federico; Donald A Goldmann; David W Bates Journal: Pediatrics Date: 2003-04 Impact factor: 7.124
Authors: Yong Y Han; Joseph A Carcillo; Shekhar T Venkataraman; Robert S B Clark; R Scott Watson; Trung C Nguyen; Hülya Bayir; Richard A Orr Journal: Pediatrics Date: 2005-12 Impact factor: 7.124
Authors: Melissa T Baysari; Jessica Del Gigante; Maria Moran; Indy Sandaradura; Ling Li; Katrina L Richardson; Anmol Sandhu; Elin C Lehnbom; Johanna I Westbrook; Richard O Day Journal: Appl Clin Inform Date: 2017-09-13 Impact factor: 2.342
Authors: Erin F Hoehn; Kevin M Overmann; Nafeh Fananapazir; Kirsten Simonton; Kathi L Makoroff; Berkeley L Bennett; Elena M Duma; Eileen Murtagh Kurowski Journal: Pediatrics Date: 2018-11-09 Impact factor: 7.124
Authors: Sharon Conroy; Dimah Sweis; Claire Planner; Vincent Yeung; Jacqueline Collier; Linda Haines; Ian C K Wong Journal: Drug Saf Date: 2007 Impact factor: 5.606
Authors: Christopher E Kandel; Suzanne Gill; Janine McCready; John Matelski; Jeff E Powis Journal: BMC Infect Dis Date: 2016-07-22 Impact factor: 3.090
Authors: Andre Kumar; Rachael C Aikens; Jason Hom; Lisa Shieh; Jonathan Chiang; David Morales; Divya Saini; Mark Musen; Michael Baiocchi; Russ Altman; Mary K Goldstein; Steven Asch; Jonathan H Chen Journal: J Am Med Inform Assoc Date: 2020-12-09 Impact factor: 4.497